Financials Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:02 2025-02-14 pm EST 5-day change 1st Jan Change
76.19 USD +0.25% Intraday chart for Edwards Lifesciences Corporation +8.30% +2.92%

Projected Income Statement: Edwards Lifesciences Corporation

Forecast Balance Sheet: Edwards Lifesciences Corporation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 -585 -588 -267 -173 -1,048 -3,692 -3,658 -4,617
Change - -200.51% -145.41% -164.79% -705.78% -452.46% -199.08% -226.22%
Announcement Date 1/30/20 1/27/21 1/26/22 1/31/23 2/6/24 2/11/25 - -
1USD in Million
Estimates

Cash Flow Forecast: Edwards Lifesciences Corporation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
CAPEX 1 254.4 407 325.8 244.6 253 288.8 259.2 287.7
Change - 59.98% -19.95% -24.92% 3.43% 14.15% -10.24% 11%
Free Cash Flow (FCF) 1 925 647.3 1,406 973.6 943 1,268 1,407 1,552
Change - -30.02% 117.26% -30.77% -3.14% 34.45% 10.97% 10.28%
Announcement Date 1/30/20 1/27/21 1/26/22 1/31/23 2/6/24 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Edwards Lifesciences Corporation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026

Profitability

        
EBITDA Margin (%) 32.33% 32.58% 33.05% 35.97% 31.29% 30.43% 30.21% 30.87%
EBIT Margin (%) 30.28% 30.14% 30.47% 33.38% 28.87% 27.84% 27.26% 28.09%
EBT Margin (%) 26.83% 20.9% 32.53% 32.84% 26.61% 28.46% 28.84% 29.81%
Net margin (%) 24.08% 18.77% 28.73% 28.28% 23.35% 76.75% 24.24% 24.74%
FCF margin (%) 21.27% 14.76% 26.88% 18.09% 15.7% 21.48% 24.09% 24.16%
FCF / Net Income (%) 88.36% 78.61% 93.56% 63.97% 67.24% 91.72% 99.39% 97.69%

Profitability

        
ROA 20.03% 17.11% 17.84% 18.46% 15.89% 12.76% 11.6% 12.12%
ROE 32.46% 26.92% 26.97% 26.64% 22.52% 19.23% 15.71% 15.25%

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - - -
Debt / Free cash flow - - - - - - - -

Capital Intensity

        
CAPEX / Current Assets (%) 5.85% 9.28% 6.23% 4.54% 4.21% 4.89% 4.44% 4.48%
CAPEX / EBITDA (%) 18.1% 28.48% 18.84% 12.63% 13.47% 16.08% 14.69% 14.52%
CAPEX / FCF (%) 27.5% 62.88% 23.17% 25.12% 26.83% 22.78% 18.43% 18.55%

Items per share

        
Cash flow per share 1 1.853 1.668 2.74 1.952 1.47 0.1374 2.833 3.172
Change - -9.94% 64.22% -28.76% -24.69% -90.65% 1,961.41% 11.97%
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 6.504 7.188 9.351 9.546 10.91 14.99 17.06 17.39
Change - 10.51% 30.1% 2.09% 14.31% 37.34% 13.85% 1.9%
EPS 1 1.643 1.3 2.38 2.44 2.3 6.97 2.384 2.7
Change - -20.89% 83.08% 2.52% -5.74% 203.04% 3.31% 13.25%
Nbr of stocks (in thousands) 625,710 623,248 624,334 618,260 606,500 589,800 589,800 589,800
Announcement Date 1/30/20 1/27/21 1/26/22 1/31/23 2/6/24 2/11/25 - -
1USD
Estimates
2024 2025 *
P/E ratio 10.6x 32x
PBR 5.08x 4.47x
EV / Sales 8.03x 7.07x
Yield - -
More valuation ratios * Estimated data

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
76.19USD
Average target price
80.42USD
Spread / Average Target
+5.55%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EW Stock
  4. Financials Edwards Lifesciences Corporation